NASDAQ: CDNA Investor Notice: CareDx, Inc Is Under Investigation
An investigation for investors in CareDx, Inc (NASDAQ: CDNA) shares over potential securities laws violations by CareDx, Inc was announced.
San Diego, CA -- (SBWire) -- 08/02/2019 --An investigation was announced concerning potential securities laws violations by CareDx, Inc.
Investors who purchased shares of CareDx, Inc (NASDAQ: CDNA), have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by CareDx, Inc (regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Brisbane, CA based CareDx, Inc., a transplant diagnostics company, together with its subsidiaries, focuses on the discovery, development, and commercialization of diagnostic solutions for transplant patients worldwide.
In 2017, CareDx, Inc launched its AlloSure product for kidney transplant recipients. AlloSure is designed to check for cell-free DNA associated with organ rejection, a serious problem with kidney transplants. AlloSure is currently responsible for 83% of CareDx, Inc's total revenue.
CareDx, Inc reported that its annual Total Revenue rose from $48.32 million in 2017 to $76.56 million in 2018 and that its Net Loss declined from $55.46 million in 2017 to $46.75 million in 2018.
On July 16, 2019, a report noted that the AlloSure test manufactured by CareDx isn't nearly as popular as it seems because it misses around 40% of organ rejections compared to the current standard of care.
Shares of CareDx, Inc (NASDAQ: CDNA) closed on July 25, 2019, at $31.29 per share.
Those who purchased shares of CareDx, Inc (NASDAQ: CDNA) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in conftact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
Media Relations Contact
View this press release online at: http://rwire.com/1251109